FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Start Quality Metrics Targeted Program: ISPE

[ Price : $8.95]

The International Society for Pharmaceutical Engineering calls on FDA to use a targeted, phased-in approach to start its quality m...

FasterCures Suggestions for Patient Perspective Info

[ Price : $8.95]

FasterCures recommends PDUFA 6 language to build collection of patient perspective data into medical product development and regul...

Concordia Wants Changes for Generic Digoxin Drugs

[ Price : $8.95]

Concordia asks FDA to update its digoxin bioequivalence guidance with testing recommendations from an advisory committee.

Researchers Identify New Lung Cancer Biomarker

[ Price : $8.95]

Researchers in Taiwan say they have identified a biomarker that detects the most common lung cancer in its earliest stage, which c...

FDA Clears Gmate Smartphone Blood Glucose Monitor

[ Price : $8.95]

FDA clears a Philosys 510(k) for the Gmate Smart Blood Glucose Monitoring System and app for Android smartphones.

FDA Closes Out Warning Letters Sent to AngioDynamics

[ Price : $8.95]

FDA issues close-out letters to AngioDynamics involving Warning Letters in 2011 about its Queensbury, NY facility and in 2014 abou...

Warning Letters Sent to Picamilon Supplement Makers

[ Price : $8.95]

FDA sends five Warning Letters to manufacturers marketing dietary supplements containing picamilon as a dietary ingredient, asking...

FDA Accepts Medicure sNDA for Aggrastat

[ Price : $8.95]

FDA accepts for review a Medicure supplemental NDA for Aggrastat (tirofiban HCl) that seeks an expanded indication to include trea...

Guidance on Blood Donor Suitability in Ebola Outbreaks

[ Price : $8.95]

Federal Register Notice: FDA releases a draft guidance: Recommendations for Assessment of Blood Donor Suitability, Donor Deferral ...

CBE Rule Delay Risking Generic Drug Patients: Public Citizen

[ Price : $8.95]

Public Citizen calls on FDA to quickly finalize its proposed rule to allow generic drug manufacturers to update safety warnings wi...